Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

VINORELBINE INJECTION, USP DIN 02392445

Status: Cancelled Pre Market
Holder: MYLAN PHARMACEUTICALS ULC
Molecule: VINORELBINE (VINORELBINE TARTRATE)

Health Canada record

Active ingredient(s)VINORELBINE (VINORELBINE TARTRATE) 10 MG
Dosage formSolution
RouteIntravenous
SchedulePRESCRIPTION
ClassHuman
ATCL01CA04 VINORELBINE
Original market date
Current status date28-Feb-2022
SourceHealth Canada DPD

Establishment licence of the holder

Mylan Pharmaceuticals ULC — licence 101774, currently licensed, last inspection rating C (2026-02-24).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing VINORELBINE (VINORELBINE TARTRATE)

DINProductCompanyFormStrengthStatus
02511347VINORELBINE INJECTION, USPFRESENIUS KABI CANADA LTDSolutionVINORELBINE (VINORELBINE TARTRATE) 10 MGMarketed
02431130VINORELBINE INJECTION, USPGENERIC MEDICAL PARTNERS INCSolutionVINORELBINE (VINORELBINE TARTRATE) 10 MGMarketed
02271214VINORELBINE TARTRATE FOR INJECTIONTEVA CANADA LIMITEDSolutionVINORELBINE (VINORELBINE TARTRATE) 10 MGMarketed
02396416AJ-VINORELBINEAGILA JAMP CANADA INCSolutionVINORELBINE (VINORELBINE TARTRATE) 10 MGCancelled Pre Market
02091283NAVELBINEPIERRE FABRE PHARMA CANADA INCSolutionVINORELBINE (VINORELBINE TARTRATE) 10 MGCancelled Post Market
02265990VINORELBINE INJECTIONFRESENIUS KABI CANADA LTDSolutionVINORELBINE (VINORELBINE TARTRATE) 10 MGCancelled Post Market
02257777VINORELBINE TARTRATE FOR INJECTIONPFIZER CANADA ULCSolutionVINORELBINE (VINORELBINE TARTRATE) 10 MGCancelled Post Market
02327643VINORELBINE TARTRATE INJECTION USPSANDOZ CANADA INCORPORATEDSolutionVINORELBINE (VINORELBINE TARTRATE) 10 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
157442014-06-24Abbreviated New Drug Submission (ANDS)MERGER - BUYOUT
136002012-08-24Abbreviated New Drug Submission (ANDS)
Request a quote for VINORELBINE INJECTION, USP

How to read a Canadian DIN record